Phase II trial of androgen deprivation therapy (ADT) and pembrolizumab for advanced stage androgenreceptor-positive salivary gland carcinoma: Big Ten Cancer Research Consortium BTCRC-HN17-111

Project: Research project


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences